FDA approves Pfizer's Relpax

The FDA granted marketing approval for PFE's Relpax eletriptan to treat acute migraines. Relpax is a selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonist that acts at serotonin 5HT1B recep...